YOLFTbeta
Aprogen KIC Inc

Aprogen KIC Inc

007460 · KO · Industrials / Conglomerates

1,881.00KRW-4.00 (-0.21%)

Price History

Full chart

Market Stats

Previous Close1,885.00
Open1,863.00
Day Range1,863.00 – 1,924.00
52-Week Range1,875.00 – 14,070.00
Volume36.07K
Market Cap43.84B
P/E (TTM)0.00
Forward P/E0.00
Dividend Yield0.00%
Beta0.10
50-Day Avg2,249.14
200-Day Avg4,948.75

About

Aprogen Medicines Inc. designs, manufactures, and maintains plant facilities for steelwork, petrochemistry, shipbuilding, power plant, and LNG base industries in South Korea. The company also offers thermal and cold spray services; and clad rolls, clad plates, wear plates, clad pipes and fittings, and plasma transferred arcs. In addition, it provides Nukon system, a special heat-preservation system that keeps the pipe facility of the internal equipment of the containment building working safely in the pressurized water reactor power plant; foamglas, a cellular glass insulation product; and fireproof insulation works in the POSCO furnaces and boilers. The company was formerly known as Aprogen KIC Inc. and changed its name to Aprogen Medicines Inc. April 2021. Aprogen Medicines Inc. was founded in 2000 and is based in Seongnam-si, South Korea.

Company Details

  • SectorIndustrials
  • IndustryConglomerates
  • CEOKi-Cheol Lim
  • Employees253
  • HeadquartersHallasigma valley (Sangdaewon-dong), Seongnam-si, South Korea, Korea
  • Websitehttps://www.aprogen.com

Leadership

  • Ki-Cheol LimChief Executive Officer and Director · b. 1946

Financials

Income Statement

Currency: KRW2002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue75.26B84.04B92.80B108.36B105.64B129.42B273.13B226.33B232.26B115.62B170.69B54.84B44.90B51.05B78.25B127.14B141.25B78.35B150.58B150.11B117.97B
Growth (%)-+11.67%+10.42%+16.77%-2.51%+22.51%+111.04%-17.14%+2.62%-50.22%+47.63%-67.87%-18.12%+13.70%+53.29%+62.48%+11.09%-44.53%+92.19%-0.31%-21.41%
Cost of Revenue58.02B67.27B72.47B86.27B81.61B101.76B230.60B185.22B197.50B82.44B139.33B44.90B40.60B41.86B58.89B92.68B110.00B72.20B114.77B115.21B84.73B
Gross Profit-------36.83B50.49B33.18B31.36B9.94B4.30B9.18B19.36B34.46B31.25B6.15B35.81B34.90B33.24B
Gross Margin-------16.27%21.74%28.70%18.37%18.13%9.57%17.99%24.74%27.11%22.12%7.85%23.78%23.25%28.18%
Operating Expense-------19.37B40.03B15.97B8.12B4.88B2.47B7.61B16.79B30.49B33.92B120.51B124.67B121.71B128.81B
Operating Income4.97B5.97B9.12B9.87B10.24B11.54B21.19B17.46B10.46B17.21B23.23B5.06B1.83B1.57B2.57B3.97B-2.67B-114.35B-88.87B-86.81B-95.57B
Operating Margin6.61%7.11%9.82%9.11%9.69%8.92%7.76%7.71%4.51%14.89%13.61%9.24%4.08%3.08%3.28%3.12%-1.89%-145.95%-59.02%-57.83%-81.01%
EBITDA------------4.92B741.43M29.32B-29.58B6.50B-77.31B-65.54B-73.38B-113.95B
EBITDA Margin------------10.95%1.45%37.47%-23.26%4.60%-98.68%-43.52%-48.88%-96.59%
Net Income2.49B2.24B1.92B4.30B6.91B6.91B9.75B4.40B-12.79B-48.28B-12.07B2.41B2.34B-32.11B11.71B-46.49B-18.00B-98.66B-55.62B-58.08B-70.20B
Net Income Margin3.31%2.67%2.07%3.97%6.54%5.34%3.57%1.94%-5.51%-41.76%-7.07%4.39%5.21%-62.90%14.97%-36.57%-12.75%-125.92%-36.94%-38.69%-59.51%
R&D-------1.88B1.70B81.36M364.06M359.75M407.05M4.38B1.87B1.03B1.98B38.56B42.82B56.83B51.70B
R&D as % of Total Revenue-------0.83%0.73%0.07%0.21%0.66%0.91%8.58%2.39%0.81%1.40%49.22%28.44%37.86%43.83%
Interest Expense000000000000020.71B9.15B5.23B11.42B9.91B631.84M1.01B4.76B
Interest Expense % of Total Revenue0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%40.58%11.69%4.11%8.09%12.64%0.42%0.67%4.04%

Balance Sheet

Currency: KRW2002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets69.17B94.27B98.19B106.44B128.64B160.53B280.06B320.50B340.98B350.61B342.38B78.58B266.99B395.16B654.44B834.41B824.11B599.85B594.43B609.97B717.26B
Total Liabilities50.55B75.89B78.19B80.46B95.31B101.31B167.81B202.45B237.70B344.29B349.66B43.26B117.43B199.64B127.49B144.27B119.75B138.85B176.74B169.88B258.65B
Total Equity18.62B18.38B19.99B25.98B33.33B57.15B111.36B117.02B103.15B36.36B40.00B35.32B149.56B195.51B303.35B319.08B335.95B215.09B147.80B158.63B158.31B
Cash14.43B7.31B6.15B10.30B8.26B12.04B13.49B17.40B15.52B4.56B1.18B442.33M112.11B59.93B71.67B96.62B62.38B43.07B35.68B37.16B45.15B
Net Debt-------------109.55B12.50B-15.66B45.62B87.88B75.62B140.97B

Cash Flow

Currency: KRW2002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow4.94B3.05B5.34B3.84B475.98M-3.62B4.45B19.78B6.96B24.57B2.73B8.07B-1.49B-1.12B22.53B-84.74B-113.49B-58.16B-44.99B-32.66B
Investing Cash Flow---1.29B----38.53B-54.63B-18.74B14.95B--84.43B-210.05B-151.41B-168.49B-12.79B70.17B---
Financing Cash Flow10.25B20.03B2.05B-21.20B24.84B63.78B37.68B30.83B-888.09M-42.18B-188.04B159.34B164.22B171.01B110.40B70.80B---
Capital Expenditure8.29B14.87B1.44B1.94B3.58B5.43B14.16B16.13B25.58B8.68B18.18B1.33B78.29M4.04B7.85B2.58B34.39B19.61B54.88B23.14B32.20B
Free Cash Flow------------8.00B-5.53B-9.29B19.41B-10.72B-138.31B-113.04B-68.14B-64.86B
Dividends Paid215.00M191.45M239.48M235.18M335.98M345.98M806.36M-------------84.58K
FCF to OCF------------99.03%371.22%832.93%86.15%12.65%121.87%194.37%151.44%198.61%
Dividend Paid to FCF---------------------0.00%

Earnings

Report DateJun 1, 2009Jun 30, 2009Nov 13, 2009Feb 26, 2010Jun 1, 2011Aug 31, 2011Nov 30, 2011May 30, 2012Aug 29, 2012Nov 28, 2012Feb 27, 2013May 29, 2013Aug 28, 2013Nov 27, 2013Feb 26, 2014May 28, 2014Sep 3, 2014Dec 3, 2014Feb 25, 2015Jun 3, 2015Sep 2, 2015Dec 2, 2015Mar 2, 2016Jun 1, 2016Aug 16, 2016Nov 14, 2016Mar 15, 2017May 15, 2017Aug 14, 2017Nov 14, 2017Feb 27, 2018May 15, 2018Aug 14, 2018Nov 14, 2018Jan 30, 2019May 15, 2019Aug 14, 2019Nov 14, 2019Feb 10, 2020May 13, 2020Aug 12, 2020Nov 12, 2020May 17, 2021Aug 17, 2021Nov 18, 2021May 17, 2022Aug 12, 2022Nov 14, 2022Mar 27, 2023May 15, 2023Aug 15, 2023Nov 15, 2023May 14, 2024Aug 14, 2024Nov 13, 2024Apr 7, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
EPS Estimate47925.0069075.0018675.006750.00---------------------------------------------------------
EPS Actual31950.0040725.0021600.00-151874.9924159.03-269192.22-13628.0111704.04-73625.65-10376.78-224114.40-12445.19-263168.503108.69-33208.4518496.757735.703841.9023653.148187.154308.2482.75-3866.576333.47141.52-160.6728.98141.1855.0912.39120.00-154.70-415.45-339.63-985.35-46.4251.00130.0312.49-3569.95-12240.007558.87-2006.16-2741.011739.20-417.52-2432.28-1620.00-4635.24-1631.08-921.62-2122.87-1829.34-172.00-1539.4279.81-786.76-1114.14-828.53-868.20-1182.48
Surprise-33.33%-41.04%15.66%-2350.00%---------------------------------------------------------
TimingPre-market-Pre-marketPre-market--------------------Pre-marketPre-marketAfter-hoursPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketAfter-hoursPre-marketPre-marketPre-marketPre-marketPre-market----------------------

Key Statistics & Ratios

Market Cap43.84B
Enterprise Value182.88B
Trailing P/E0.00
Forward P/E0.00
PEG Ratio0.00
Price / Sales0.32
Price / Book0.74
Revenue (TTM)138.90B
Gross Profit (TTM)34.59B
EBITDA-57.12B
Profit Margin-60.14%
Operating Margin-75.71%
Return on Equity-30.36%
Return on Assets-6.78%
Shares Outstanding22.19M
Shares Float13.38M
Beta0.10
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Dividends

20071×
7546.40Dec 27, 2007
20061×
7546.40Dec 27, 2006
20051×
7546.40Dec 28, 2005
20041×
5282.48Dec 29, 2004
20031×
5282.48Dec 29, 2003
20021×
3773.20Dec 27, 2002
20012×
3773.20Dec 27, 20013018.56Jan 2, 2001
20001×
6037.12Jan 4, 2000
19991×
6037.12Jan 4, 1999
19981×
3018.56Jan 3, 1998
19971×
6037.12Jan 3, 1997
19961×
5659.80Jan 3, 1996

Stock Splits

  • May 8, 20261:15
  • Jan 19, 20231:3
  • Apr 30, 20131:5
  • Apr 20, 20123031:2399
  • Apr 29, 20085755:5146
  • Mar 21, 20081207:1144
  • Dec 21, 200110:1